Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China

BACKGROUND: The cost-effectiveness of human papillomavirus (HPV) vaccination in women pre-sexual debut has been demonstrated in many countries. This study aimed to estimate the cost-effectiveness of a 3-dose bivalent HPV vaccination at ages 12 to 55 year in both rural and urban settings in China. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yi-Jun, Zhang, Qian, Hu, Shang-Ying, Zhao, Fang-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768405/
https://www.ncbi.nlm.nih.gov/pubmed/26919850
http://dx.doi.org/10.1186/s12885-016-2207-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768405/
https://www.ncbi.nlm.nih.gov/pubmed/26919850
http://dx.doi.org/10.1186/s12885-016-2207-3

Ejemplares similares